TLDR The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.
This document presents a case report of a patient who developed permanent chemotherapy-induced alopecia (pCIA) after a stem cell transplant. The patient experienced total hair loss and minimal regrowth, which did not improve after 18 months. They then used a scalp prosthesis but eventually tried low-dose oral minoxidil (LDOM), which resulted in complete hair regrowth. This treatment option shows promise for pCIA, as previous treatments have been ineffective. Further research is needed to determine the effectiveness of LDOM in this patient population.
Cited in this study
7 / 7 results
10 citations
,
November 2021 in “JAMA Dermatology” Different types of persistent hair loss after chemotherapy respond differently to treatments.
39 citations
,
June 2021 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.
36 citations
,
November 2016 in “Australasian Journal of Dermatology” Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.
23 citations
,
December 2015 in “Anais Brasileiros de Dermatologia” Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.
67 citations
,
August 2010 in “Journal of The American Academy of Dermatology” Some chemotherapy can cause permanent hair loss.
40 citations
,
September 2007 in “Bone marrow transplantation” Certain chemotherapy drugs can cause permanent hair loss in stem cell transplant patients.
63 citations
,
May 2000 in “Australasian Journal of Dermatology” Chemotherapy and bone marrow transplant can cause permanent hair loss.